Patent · US Active

Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

US12083227B2 · kind B2 · utility

0Cited by

15References

46Claims

0Family size

Assignees

Abb Vie Inc. · US
Neurocrine Biosciences, Inc. · US

Inventors

Yihong Qiu · Gurnee, US
Yuchuan Gong · Waukegan, US
Alexander Ruggles · Lake Forest, US
Jared A. Baird · Grayslake, US
Hui Zu · North Chicago, US
Gregory A. McClelland · Lawrence, US
Anna V. Stepanenko · Del Mar, US

Key dates

Filing date	Aug 20, 2018
Grant date	Sep 10, 2024
Priority date	—
Expiry date	Oct 12, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.